CSDTXMWEHVSYPZ-UHFFFAOYSA-N
C47H48F5N11O — CID 118064603
Data last refreshed: (MolForge compound catalog, from PubChem)
About CSDTXMWEHVSYPZ-UHFFFAOYSA-N
CSDTXMWEHVSYPZ-UHFFFAOYSA-N (PubChem CID 118064603) has the molecular formula C47H48F5N11O and a molecular weight of 877.97 g/mol. Its IUPAC name is 2-[4-[4-(6-fluoro-1H-indol-3-yl)pyrazol-1-yl]piperidin-1-yl]ethanol;6-fluoro-3-(1-piperidin-4-ylpyrazol-4-yl)-1H-indole;3-[1-methyl-5-(trifluoromethyl)pyrazol-4-yl]-1H-indole.
Molecular Properties
| Compound Name | CSDTXMWEHVSYPZ-UHFFFAOYSA-N |
|---|---|
| PubChem CID | 118064603 |
| Molecular Formula | C47H48F5N11O |
| Molecular Weight | 877.97 g/mol |
| Exact Mass | 877.40 |
| IUPAC Name | 2-[4-[4-(6-fluoro-1H-indol-3-yl)pyrazol-1-yl]piperidin-1-yl]ethanol;6-fluoro-3-(1-piperidin-4-ylpyrazol-4-yl)-1H-indole;3-[1-methyl-5-(trifluoromethyl)pyrazol-4-yl]-1H-indole |
| SMILES | Cn1ncc(-c2c[nH]c3ccccc23)c1C(F)(F)F.Fc1ccc2c(-c3cnn(C4CCNCC4)c3)c[nH]c2c1.OCCN1CCC(n2cc(-c3c[nH]c4cc(F)ccc34)cn2)CC1 |
| InChI | InChI=1S/C18H21FN4O.C16H17FN4.C13H10F3N3/c19-14-1-2-16-17(11-20-18(16)9-14)13-10-21-23(12-13)15-3-5-22(6-4-15)7-8-24;17-12-1-2-14-15(9-19-16(14)7-12)11-8-20-21(10-11)13-3-5-18-6-4-13;1-19-12(13(14,15)16)10(7-18-19)9-6-17-11-5-3-2-4-8(9)11/h1-2,9-12,15,20,24H,3-8H2;1-2,7-10,13,18-19H,3-6H2;2-7,17H,1H3 |
| InChIKey | CSDTXMWEHVSYPZ-UHFFFAOYSA-N |
| XLogP | 9.48 |
| TPSA | 136.33 Ų |
| H-Bond Donors | 5 |
| H-Bond Acceptors | 9 |
| Rotatable Bonds | 7 |
| Heavy Atoms | 64 |
| Complexity | — |
Lipinski Rule of Five
2 violations
| Rule | Value |
|---|---|
| MW ≤ 500 | 877.97 |
| LogP ≤ 5 | 9.48 |
| H-Bond Donors ≤ 5 | 5 |
| H-Bond Acceptors ≤ 10 | 9 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 118064603 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.